头颈部癌小淋巴结转移诊断成像改进的意义:放疗靶区转化与剂量降级
诊断成像对小淋巴结转移的检出精度空前提高,使原本亚临床、被纳入选择性靶区的小转移灶如今被检出并归入高剂量靶区,导致高剂量靶区更常包含低体积病变。本文评估现代颈部成像所致靶区转化的放射生物学后果,并提出头颈部癌放疗剂量降低的理论推导方案;该靶区转化与剂量适应策略概念也适用于其他多种肿瘤类型。
要点
- 现代成像使原本亚临床的小淋巴结转移被检出并纳入高剂量靶区,高剂量靶区更常含低体积病变。
- 颈部传统淋巴结大体肿瘤体积最小直径通常为10–15 mm,如今可检出更小的淋巴结内肿瘤沉积。
- 选择性淋巴结照射的现行剂量水平于20世纪50年代经验性确定,此后未改变。
核心结论
- 现代成像导致的靶区转化具有放射生物学后果,文中据此提出头颈部癌放疗剂量降低的理论推导方案。
- 靶区转化及后续剂量适应策略的概念也适用于其他多种肿瘤类型,认识该概念可能产生新的靶区定义与剂量水平选择策略,以在更少毒性下实现最佳肿瘤控制。
研究设计与样本
- 本文为针对诊断成像改进所致靶区转化的放射生物学后果进行评估并提出理论推导剂量降低方案的报告,原文未报告研究样本量。
主要发现
- 小转移灶过去保持亚临床并被纳入选择性体积,如今被检出并纳入高剂量体积,高剂量体积因而更常包含低体积病变。
- 颈部淋巴结分期已从单纯触诊演变为多种高分辨率成像模态的组合。
- 颈部传统淋巴结大体肿瘤体积最小直径通常为10–15 mm,如今可检出更小的淋巴结内肿瘤沉积。
- 选择性淋巴结照射的现行剂量水平于20世纪50年代经验性确定,此后未改变。
关键数值与推荐
- 颈部传统淋巴结大体肿瘤体积最小直径通常为10–15 mm。
- 选择性淋巴结照射的现行剂量水平于20世纪50年代经验性确定,此后未改变。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diagnostic imaging continues to evolve, and now has unprecedented accuracy for detecting small nodal metastasis. This influences the tumor load in elective target volumes and subsequently has consequences for the radiotherapy dose required to control disease in these volumes. Small metastases that used to remain subclinical and were included in elective volumes, will nowadays be detected and included in high-dose volumes. Consequentially, high-dose volumes will more often contain low-volume disease. These target volume transformations lead to changes in the tumor burden in elective and "gross" tumor volumes with implications for the radiotherapy dose prescribed to these volumes. For head and neck tumors, nodal staging has evolved from mere palpation to combinations of high-resolution imaging modalities. A traditional nodal gross tumor volume in the neck typically had a minimum diameter of 10-15 mm, while nowadays much smaller tumor deposits are detected in lymph nodes. However, the current dose levels for elective nodal irradiation were empirically determined in the 1950s, and have not changed since. In this report the radiobiological consequences of target volume transformation caused by modern imaging of the neck are evaluated, and theoretically derived reductions of dose in radiotherapy for head and neck cancer are proposed. The concept of target volume transformation and subsequent strategies for dose adaptation applies to many other tumor types as well. Awareness of this concept may result in new strategies for target definition and selection of dose levels with the aim to provide optimal tumor control with less toxicity.
引用
- van den Bosch S, Vogel WV, Raaijmakers CP, et al. Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation. Radiother Oncol. 2018. PMID: 29731161. doi:10.1016/j.radonc.2018.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。